FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

François Raffi

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Procedures

Concepts & Ideas

Geographic Areas

France

Activities & Behaviors

Patient Compliance

Co-author Network

Publications

TOP 3
Marie-Laure Chaix; Pierre Frange; Jade Ghosn; Cécile Goujard; Laurence Meyer; François Raffi; Jacques Reynes; Christine Rouzioux; Remonie Seng; Laurent Tran; Yazdan Yazdanpanah; Véronique Avettand-Fenoël
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Véronique Joly; François Raffi; Sophie Tabuteau; Yazdan Yazdanpanah; Patrick Yeni; André Cabie; Charlotte Charpentier; Geneviève Chene; Nathalie Colin de Verdiere; Diane Descamps; Catherine Fagard; Carine Grondin
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Eric Dailly; Guillaume Deslandes; Clotilde Allavena; Regis Bouquié; François Raffi; Pascale Jolliet
Effect of efavirenz, nevirapine, etravirine, and raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of François Raffi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marie-Laure Chaix; Pierre Frange; Jade Ghosn; Cécile Goujard; Laurence Meyer; François Raffi; Jacques Reynes; Christine Rouzioux; Remonie Seng; Laurent Tran; Yazdan Yazdanpanah; Véronique Avettand-Fenoël
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(6):880-7.
2013: Véronique Joly; François Raffi; Sophie Tabuteau; Yazdan Yazdanpanah; Patrick Yeni; André Cabie; Charlotte Charpentier; Geneviève Chene; Nathalie Colin de Verdiere; Diane Descamps; Catherine Fagard; Carine Grondin
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrobial agents and chemotherapy 2013;57(2):758-65.
2013: Eric Dailly; Guillaume Deslandes; Clotilde Allavena; Regis Bouquié; François Raffi; Pascale Jolliet
Effect of efavirenz, nevirapine, etravirine, and raltegravir administration on the pharmacokinetics of ritonavir-boosted darunavir in a population of HIV-infected patients.
AIDS research and human retroviruses 2013;29(1):42-6.
2012: Antoine Biron; Jean-Marie Bard; Martine Billard; Christine Bobin-Dubigeon; Thomas Jovelin; Catherine Leport; Philippe Perré; Lionel Piroth; Thierry Prazuck; François Raffi; Véronique Sébille; Christelle Volteau; Charlotte Biron
Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
AIDS research and human retroviruses 2012;28(12):1672-8.
2012: Eric Dailly; Guillaume Deslandes; Virginie Ferré; Elisabeth Garnier; Clotilde Allavena; Eric Billaud; Régis Bouquié; François Raffi; Véronique Reliquet; Audrey Rodallec; Pascale Jolliet
Virological response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacological parameters.
Fundamental & clinical pharmacology 2012;26(4):538-42.
2012: Hassan Nazih; François Raffi; Jacques Reynes; Audrey Taïeb; Jean-Marie Bard; Jill-Patrick Cassuto; Geneviève Chêne; Patrick Choutet; Tristan Ferry; Catherine Leport
Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE study.
AIDS research and human retroviruses 2012;28(4):393-9.
2012: Maria Patrizia Carrieri; Lise Cuzin; Vincent Le Moing; Catherine Leport; Sophie Mahy; Camelia Protopopescu; François Raffi; Philippe Reboud; Perrine Roux; Bruno Spire
Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy.
BMJ open 2012;2(6):.
2012: Camelia Protopopescu; François Raffi; Philippe Reboud; Dominique Salmon; Bruno Spire; Renaud Verdon; Cécile Brunet-François; Maria Patrizia Carrieri; Catherine Leport; Laurent Michel
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Antiviral therapy 2012;17(6):1079-83.
2012: Marie Préau; Camelia Protopopescu; François Raffi; J M Ragnaud; D Rey; Bruno Spire; Geneviève Chêne; Catherine Leport; Fabienne Marcellin; C Perronne
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012;24(4):434-43.
2012: Clotilde Allavena; André Cabié; Lise Cuzin; Pierre Dellamonica; Claudine Duvivier; Philippe Flandre; Hugues Melliez; Isabelle Poizot-Martin; Pascal Pugliese; François Raffi; Marc-Antoine Valantin
Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.
Scandinavian journal of infectious diseases 2012;44(1):37-43.
2011: Yovana Pacheco; Ariane Plet; François Raffi; Véronique Solé; Clotilde Allavena; Eric Billaud; Virginie Ferré; laure garrigue-antar; Yannick Jacques; Dorian McIlroy
Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.
AIDS (London, England) 2011;25(14):1701-10.
2011: C Biron; David Boutoille; V Briend-Godet; F Corne; J Esbelin; I Hazart; A Ponge; O Beaudoux; A Biron; D Tripodi; François Raffi
[Measles in the Nantes Teaching Hospital during the 2008-2009 epidemic].
Médecine et maladies infectieuses 2011;41(8):415-23.
2011: Yovana Pacheco; François Raffi; Audrey Rodallec; Sandra M Mueller-Schmucker; Clotilde Allavena; Elisabeth André-Garnier; Eric Billaud; François Cleon; Virginie Ferré; Yannick Guilloux; Thomas Harrer; Angela G Hueckelhoven; Dorian McIlroy
The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.
Journal of clinical immunology 2011;31(4):681-9.
2011: Odile Launay; Pierre Loulergue; Gilles Pialoux; François Raffi; David Rey; Jacques Reynes; François Roman; Jean-Pierre Aboulker; Faiza Ajana; Nathalie Colin de Verdière; Jean-François Delfraissy; Corinne Desaint; Jeanne-Marie Devaster; Christine Durier; Xavier Duval; Valérie Foubert; Jade Ghosn; Christine Jacomet
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.
The Journal of infectious diseases 2011;204(1):124-34.
2011: Lauriane Goldwirt; Caroline Lascoux-Combe; François Raffi; Anne-Marie Taburet; Jean-Pierre Aboulker; Aurélie Barrail-Tran; Joséphine Braun; Isabelle Charreau; Nathalie de Castro; Constance Delaugerre; Jean-Michel Molina
Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.
Antimicrobial agents and chemotherapy 2011;55(7):3613-5.
2011: Jade Ghosn; François Raffi; Christine Rouzioux; Isabelle Cohen-Codar; Constance Delaugerre; Jean-François Delfraissy; Philippe Flandre; Julie Galimand; Marie-Laure Chaix
Polymorphism in Gag gene cleavage sites of HIV-1 non-B subtype and virological outcome of a first-line lopinavir/ritonavir single drug regimen.
PloS one 2011;6(9):e24798.
2010: S Pineau; J-P Talarmin; Florent Morio; O Grossi; David Boutoille; F Léauté; Patrice LE PAPE; Françoise Gay-Andrieu; Michel Miegeville; François Raffi
[Contribution of molecular biology and Aspergillus galactomannan antigen assay for the diagnosis of histoplasmosis].
Médecine et maladies infectieuses 2010;40(9):541-3.
2010: Nathalie Asseray; Christophe Papin; Sophie Touchais; Pascale Bemer; Chantal Lambert; David Boutoille; Brigitte Tequi; François Gouin; François Raffi; Norbert Passuti; Gilles Potel
Improving diagnostic criteria for Propionibacterium acnes osteomyelitis: a retrospective analysis.
Scandinavian journal of infectious diseases 2010;42(6-7):421-5.
2010: J-J Laurichesse; A Taieb; C Capoulade-Metay; Christine Katlama; V Villes; M-C Drobacheff-Thiebaud; François Raffi; Geneviève Chêne; I Theodorou; Catherine Leport
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?
HIV medicine 2010;11(4):239-44.
2010: Véronique Reliquet; Clotilde Allavena; P Morineau-Le Houssine; O Mounoury; François Raffi
Twelve-year experience of nevirapine use: benefits and convenience for long-term management in a French cohort of HIV-1-infected patients.
HIV clinical trials 2010;11(2):110-7.
2009: J-P Talarmin; David Boutoille; Pierre Tattevin; S Dargère; Pierre Weinbreck; S Ansart; JM Chennebault; P Hutin; S Léautez-Nainville; Françoise Gay-Andrieu; François Raffi
[Epidemiology of candidemia: a one-year prospective observational study in the west of France].
Médecine et maladies infectieuses 2009;39(12):877-85.
2009: J Martin; G Deslandes; Eric Dailly; C Renaud; Véronique Reliquet; François Raffi; Pascale Jolliet
A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(27):3072-82.
2009: Camelia Protopopescu; François Raffi; Perrine Roux; Jacques Reynes; Pierre Dellamonica; Bruno Spire; Catherine Leport; Maria Patrizia Carrieri
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
The Journal of antimicrobial chemotherapy 2009;64(3):599-606.
2009: Tristan Ferry; François Raffi; Fidéline Collin-Filleul; Michel Dupon; Pierre Dellamonica; Anne Waldner; Christophe Strady; Geneviève Chêne; Catherine Leport; Vincent Le Moing
Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
Journal of acquired immune deficiency syndromes (1999) 2009;51(4):407-15.
2009: Patrick Peretti-Watel; Virginie Villes; Xavier Duval; Fidéline Collin; Jacques Reynes; Alain Sobel; Camelia Protopopescu; Geneviève Chêne; Bruno Spire; François Raffi
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort.
Current HIV research 2009;7(4):462-7.
2009: Fidéline Collin; Xavier Duval; Vincent Le Moing; Lionel Piroth; Firas Al Kaied; Patrice Massip; Virginie Villes; Geneviève Chêne; François Raffi
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.
AIDS (London, England) 2009;23(8):1021-4.
2009: Laurent Dacheux; Florence Larrous; Alexandra Mailles; Didier Boisseleau; Olivier Delmas; Charlotte Biron; Christiane Bouchier; Isabelle Capek; Michel Muller; Frédéric Ilari; Tanguy Lefranc; François Raffi; M Goudal; Hervé Bourhy
European bat Lyssavirus transmission among cats, Europe.
Emerging infectious diseases 2009;15(2):280-4.
2008: O Grossi; J P Talarmin; D Boutoille; R Frioux; S Corvec; François Raffi
[Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Médecine et maladies infectieuses 2008;38 Spec No 2():10-2.
2008: Anne-Geneviève Marcelin; Philippe Flandre; Jean-Michel Molina; Christine Katlama; Patrick Yeni; François Raffi; Zeina Antoun; Mounir Ait-Khaled; Vincent Calvez
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
Antimicrobial agents and chemotherapy 2008;52(12):4251-7.
2008: Khadija Ouguerram; Yassine Zair; Stéphanie Billon; Maud Chétiveaux; Cécile Brunet-François; Kalyane Ngohou-Bach; Clotilde Allavena; Veronique Reliquet; Brigitte Milpied; Thierry Magot; François Raffi; Michel Krempf
Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.
Medicinal chemistry (Shāriqah (United Arab Emirates)) 2008;4(6):544-50.
2008: Gerd Fätkenheuer; Mark Nelson; Adriano Lazzarin; Irina Konourina; Andy I M Hoepelman; Harry Lampiris; Bernard Hirschel; Pablo Tebas; François Raffi; Benoit Trottier; Nicholaos Bellos; Michael Saag; David A Cooper; Mike Westby; Margaret Tawadrous; John F Sullivan; Caroline Ridgway; Michael W Dunne; Steve Felstead; Howard Mayer; Elna van der Ryst
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
The New England journal of medicine 2008;359(14):1442-55.
2008: Charlotte Lewden; Geneviève Chêne; Philippe Morlat; François Raffi; François Dabis; Catherine Leport
[Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results].
Médecine sciences : M/S 2008;24(10):804-6.
2008: Clotilde Allavena; Thierry Prazuck; Véroniquer Reliquet; Renaud Verdon; Philippe Perré; Gwenael Le Moal; Eric Billaud; François Raffi
Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study).
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2008;7(4):187-92.
2008: Didier Neau; Pascale Trimoulet; Edwige Pereira; Marie-Edith Lafon; Anne Gervais; Jean-Marie Ragnaud; Michel Dupon; Jean-Luc Ecobichon; Geneviève Chêne; François Raffi
Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.
Journal of acquired immune deficiency syndromes (1999) 2008;48(2):227-9.
2008: Jade Ghosn; Marie-Laure Chaix; Gilles Peytavin; Jean-Louis Bresson; Julie Galimand; Pierre-Marie Girard; François Raffi; Isabelle Cohen-Codar; Jean-François Delfraissy; Christine Rouzioux
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
The Journal of antimicrobial chemotherapy 2008;61(6):1344-7.
2008: Marie Préau; Catherine Leport; Virginie Villes; Christian Michelet; Fidéline Collin; Maria Patrizia Carrieri; Jean-Marie Ragnaud; Audrey Taieb; François Raffi; Bruno Spire
Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):467-71.
2008: Eric Dailly; François Raffi; Charlotte Biron; Clotilde Allavena; Pascale Jolliet
Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients.
Fundamental & clinical pharmacology 2008;22(1):101-4.
2008: François Raffi; Charlotte Lewden; Geneviève Chêne
Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
AIDS (London, England) 2008;22(3):435-6.
2008: Bruno Spire; Fabienne Marcellin; Isabelle Cohen-Codar; Philippe Flandre; François Boue; Pierre Dellamonica; François Raffi; Michael Norton; Ngo Van Philippe; Jean-François Delfraissy
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
Antiviral therapy 2008;13(4):591-9.
2008: Olivier Sitbon; Caroline Lascoux-Combe; Jean-François Delfraissy; Patrick G Yeni; François Raffi; Dominique de Zuttere; Virginie Gressin; Pierre Clerson; Daniel Sereni; Gérald Simonneau
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.
American journal of respiratory and critical care medicine 2008;177(1):108-13.
2007: Charlotte Lewden; Geneviève Chene; Philippe Morlat; François Raffi; Michel Dupon; Pierre Dellamonica; Jean-Luc Pellegrin; Christine Katlama; François Dabis; Catherine Leport
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):72-7.
2007: Maria Patrizia Carrieri; Virginie Villes; François Raffi; Camelia Protopopescu; Marie Preau; Dominique Salmon; Audrey Taieb; Jean-Marie Lang; Renaud Verdon; Geneviève Chene; Bruno Spire
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).
The International journal on drug policy 2007;18(4):288-95.
2007: Bahia Amellal; Clotilde Allavena; E André-Garnier; Virginie Ferré; Marc-Antoine Valantin; Jean-François Delfraissy; Alain Lafeuillade; Manuela Bonmarchand; Vincent Calvez; François Raffi
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study).
The Journal of infection 2007;54(6):603-8.
2007: Camelia Protopopescu; Fabienne Marcellin; Bruno Spire; Marie Préau; Renaud Verdon; Dominique Peyramond; François Raffi; Geneviève Chêne; Catherine Leport; Maria Patrizia Carrieri
Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(4):577-91.
2007: Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; A Sobel; Patrice Massip; F Collin; Marie-Caroline Meyohas; F Al Kaïed; Catherine Leport; François Raffi
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.
HIV medicine 2007;8(3):156-63.
2007: Fidéline Collin; Geneviève Chêne; Sylvie Retout; Gilles Peytavin; Dominique Salmon; Elisabeth Bouvet; François Raffi; Rodolphe Garraffo; France Mentré; Xavier Duval
Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults.
Therapeutic drug monitoring 2007;29(2):164-70.
2007: C Brunet-François; Audrey Taieb; Bernard Masquelier; Vincent Le Moing; Charlotte Lewden; Pierre Dellamonica; Lise Cuzin; Clotilde Allavena; B Spire; Geneviève Chêne; François Raffi
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort].
Médecine et maladies infectieuses 2007;37(3):172-7.
2007: Jean-Michel Molina; Valérie Journot; André Furco; Pierre Palmer; Nathalie de Castro; François Raffi; Philippe Morlat; thierry may; Corinne Rancinan; Geneviève Chêne
Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).
Antiviral therapy 2007;12(3):417-22.
2006: Véronique Reliquet; Clotilde Allavena; C François-Brunet; Philippe Perré; V Bellein; Michel Garré; thierry may; Faouzi Souala; Jean-Marc Besnier; François Raffi
Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study.
HIV medicine 2006;7(7):431-6.
2006: Eric Dailly; Olivier Tribut; Pierre Tattevin; Cédric Arvieux; Philippe Perré; François Raffi; Pascale Jolliet
Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
European journal of clinical pharmacology 2006;62(7):523-6.
2006: Alain Makinson; Bernard Masquelier; Audrey Taieb; Gilles Peytavin; Anne Waldner-Combernoux; Gilles Collin; Geneviève Chêne; Françoise Brun-Vézinet; François Raffi; Vincent Le Moing; Catherine Leport; Diane Descamps
Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART.
AIDS (London, England) 2006;20(9):1327-9.
2006: Vincent Le Moing; C Rabaud; Valérie Journot; Xavier Duval; Lise Cuzin; Jill-Patrice Cassuto; F Al Kaied; Pierre Dellamonica; Geneviève Chêne; François Raffi
Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen.
HIV medicine 2006;7(4):261-7.
2006: Maria Patrizia Carrieri; Catherine Leport; Camelia Protopopescu; Jill-Patrice Cassuto; Elisabeth Bouvet; Dominique Peyramond; François Raffi; Jean-Paul Moatti; Geneviève Chêne; Bruno Spire
Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):477-85.
2006: M I Wateba; Eric Billaud; Eric Dailly; Pascale Jolliet; François Raffi
Low initial trough plasma concentrations of lopinavir are associated with an impairment of virological response in an unselected cohort of HIV-1-infected patients.
HIV medicine 2006;7(3):197-9.
2006: Eric Dailly; Véronique Reliquet; Caroline Victorri-Vigneau; François Raffi; Pascale Jolliet
A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;832(2):317-20.
2006: Jean-Marie Bard; Régis Lassalle; Jacqueline Capeau; Kalyane Bach-Ngohou; Françoise Nazih-Sanderson; Gérard Rémy; Jacques Reynes; Jean-Luc Ecobichon; Marianne Savès; François Raffi
Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
Antiviral therapy 2006;11(3):361-70.
2006: Clotilde Allavena; Gwenael Le Moal; Christophe Michau; Anne Chiffoleau; François Raffi
Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.
Antiviral therapy 2006;11(2):263-5.
2005: Eric Dailly; Marie-Claude Gagnieu; Clotilde Allavena; François Raffi; Pascale Jolliet
No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach.
Therapeutic drug monitoring 2005;27(6):782-4.
2005: Lise Cuzin; pascal pugliese; F Bugnon; Cyrille Delpierre; E Cua; Eric Billaud; Patrice Massip; François Raffi; Pierre Dellamonica
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
HIV medicine 2005;6(6):388-95.
2005: Bruno Hoen; Isabelle Fournier; Christine Lacabaratz; Marianne Burgard; Isabelle Charreau; Marie-Laure Chaix; Jean-Michel Molina; Jean-Michel Livrozet; Alain Venet; François Raffi; Jean-Pierre Aboulker; Christine Rouzioux
Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):307-16.
2005: Constance Delaugerre; Gilles Peytavin; Stephanie Dominguez; Anne-Geneviève Marcelin; Claudine Duvivier; Karine Gourlain; Bahia Amellal; Mayeule Legrand; François Raffi; Dominique Costagliola; Christine Katlama; Vincent Calvez
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Journal of medical virology 2005;77(3):345-50.
2005: Rachid Agher; Claudine Duvivier; Christine Katlama; Yann Gérard; Yazdan Yazdanpanah; Eric Billaud; T Jovelin; François Raffi; P Enel; Isabelle Poizot-Martin; P Puglièse; Pierre Dellamonica; M Barone; Lise Cuzin; Bruno Marchou
[The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals].
Médecine et maladies infectieuses 2005;35(7-8):407-10.
2005: Clotilde Allavena; Virginie Ferré; Cécile Brunet-François; Jean-François Delfraissy; Alain Lafeuillade; Marc-Antoine Valantin; Michelle Bentata; Christian Michelet; Isabelle Poizot-Martin; Eric Dailly; Odile Launay; François Raffi
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):300-6.
2005: Eric Dailly; Clotilde Allavena; François Raffi; Pascale Jolliet
Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz.
British journal of clinical pharmacology 2005;60(1):32-4.
2005: Vincent Le Moing; Geneviève Chêne; Bruno Spire; François Raffi; Catherine Leport
[Outcome of HIV-infected patients after 5 years of antiretroviral therapy including a protease inhibitor: the Aproco/Copilote Cohort].
Presse médicale (Paris, France : 1983) 2005;34(10 Suppl):1S31-7.
2005: Bernard Masquelier; Edwige Pereira; Gilles Peytavin; Diane Descamps; Jacques Reynes; Renaud Verdon; Hervé Fleury; R Garraffo; Geneviève Chêne; François Raffi; Françoise Brun-Vézinet
Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):75-8.
2005: Eric Dailly; Véronique Reliquet; François Raffi; Pascale Jolliet
A population approach to study the influence of nevirapine administration on lopinavir pharmacokinetics in HIV-1 infected patients.
European journal of clinical pharmacology 2005;61(2):153-6.
2005: Romina Quercia; Elisabeth Garnier; Virginie Ferré; Pascale Morineau; Bénédicte Bonnet; Claire Soulard; François Raffi
Salvage therapy with ritonavir-boosted amprenavir/fosamprenavir: virological and immunological response in two years follow-up.
HIV clinical trials 2005;6(2):73-80.
2005: Xavier Duval; France Mentré; Claire Lamotte; Geneviève Chêne; Bruno Spire; Pierre Dellamonica; Xavière Panhard; Dominique Salmon; François Raffi; Gilles Peytavin; Catherine Leport
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.
Therapeutic drug monitoring 2005;27(1):63-70.
2004: Eric Dailly; François Raffi; Pascale Jolliet
Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;813(1-2):353-8.
2004: Xavier Duval; Valérie Journot; Catherine Leport; Geneviève Chêne; Michel Dupon; Lise Cuzin; thierry may; Philippe Morlat; Anne Waldner; Roger Salamon; François Raffi
Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):248-55.
2004: Eric Dailly; Eric Billaud; Véronique Reliquet; Sébastien Breurec; Philippe Perré; Sophie Léautez; Pascale Jolliet; Michel Bourin; François Raffi
No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors.
European journal of clinical pharmacology 2004;60(5):343-8.
2003: Vincent Le Moing; Gilles Peytavin; Valérie Journot; Jacqueline Cottalorda; Elizabeth Bouvet; Geneviève Chêne; Marie Préau; Corinne Merle De Boever; Catherine Leport; François Raffi
Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2003;34(5):497-9.
2003: Maria Patrizia Carrieri; François Raffi; Charlotte Lewden; Alain Sobel; Christian Michelet; Valérie Cailleton; Geneviève Chêne; Catherine Leport; Jean-Paul Moatti; Bruno Spire
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.
Antiviral therapy 2003;8(6):585-94.
2003: Bernard Masquelier; Cecile Droz; Martin Dary; Christian Perronne; Virginie Ferré; Bruno Spire; Diane Descamps; François Raffi; Françoise Brun-Vézinet; Geneviève Chêne
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen.
Antimicrobial agents and chemotherapy 2003;47(11):3623-6.
2003: Marianne Savès; Geneviève Chêne; Pierre Ducimetière; Catherine Leport; Gwenaël Le Moal; Philippe Amouyel; Dominique Arveiler; Jean-Bernard Ruidavets; Jacques Reynes; Annie Bingham; François Raffi
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(2):292-8.
2003: France Roblot; Gwenaël Le Moal; Cendrine Godet; P Hutin; M Texereau; E Boyer; T Prazuck; C Lacroix; M Faouzi Souala; François Raffi; P Weinbreck; Jean-Marc Besnier; B Garo; L de Gentile; Bertrand Becq-Giraudon
Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study.
The Journal of infection 2003;47(1):19-27.
2003: Ségolène Duran; Gilles Peytavin; Patrizia Carrieri; François Raffi; Jean-Luc Ecobichon; Edwige Pereira; Gilles Patrice Cassuto; Bruno Spire; Catherine Leport
The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.
AIDS (London, England) 2003;17(7):1096-9.
2002: Bernard Masquelier; Gilles Peytavin; Catherine Leport; Cecile Droz; Ségolène Duran; Renaud Verdon; Jean-Marc Besnier; Geneviève Chêne; François Raffi; Françoise Brun-Vézinet
Mechanisms of early virologic failure in antiretroviral-naive patients starting protease inhibitor-containing regimens: the APROVIR Study.
The Journal of infectious diseases 2002;186(10):1503-7.
2002: Mauro Costa-Mattioli; Clotilde Allavena; Anne-Sophie Poirier; Sylviane Billaudel; François Raffi; Virginie Ferré
Prolonged hepatitis A infection in an HIV-1 seropositive patient.
Journal of medical virology 2002;68(1):7-11.
2002: Charlotte Lewden; François Raffi; Lise Cuzin; Valérie Cailleton; Jean-Louis Vildé; Geneviève Chêne; Clotilde Allavena; Roger Salamon; Catherine Leport
Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
The Journal of infectious diseases 2002;186(5):710-4.
2002: Philippe Flandre; Gilles Peytavin; Vincent Meiffredy; Yacine Saidi; Diane Descamps; Martine Delagnes; Françoise Brun-Vézinet; François Raffi
Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Antiviral therapy 2002;7(2):113-21.
2002: Marianne Savès; François Raffi; Jacqueline Capeau; Willy Rozenbaum; Jean-Marie Ragnaud; Christian Perronne; Arnaud Basdevant; Catherine Leport; Geneviève Chêne
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(10):1396-405.
2002: Philippe Flandre; François Raffi; Diane Descamps; Vincent Calvez; Gilles Peytavin; Vincent Meiffredy; Marine Harel; Sylvie Hazebrouck; Gilles Pialoux; Jean-Pierre Aboulker; Françoise Brun Vezinet
Final analysis of the Trilège induction-maintenance trial: results at 18 months.
AIDS (London, England) 2002;16(4):561-8.
2002: Geneviève Chêne; Emmanuelle Angelini; Laurent Cotte; Jean-Marie Lang; Philippe Morlat; Corinne Rancinan; thierry may; Valérie Journot; François Raffi; Bernard Jarrousse; Michèle Grappin; Gérard Lepeu; Jean-Michel Molina
Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):649-57.
2002: Vincent Le Moing; Rodolphe Thiébaut; Geneviève Chêne; Catherine Leport; Valérie Cailleton; Christian Michelet; Hervé Fleury; Serge Herson; François Raffi
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.
The Journal of infectious diseases 2002;185(4):471-80.
2002: Vincent Le Moing; Geneviève Chêne; Catherine Leport; Charlotte Lewden; Ségolène Duran; Michel Garré; Bernard Masquelier; Michel Dupon; François Raffi
Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):239-47.
2002: Vincent Le Moing; Geneviève Chêne; Maria Patrizia Carrieri; Ahmadou Alioum; Françoise Brun-Vézinet; Lionel Piroth; Jill-Patrice Cassuto; Jean-Paul Moatti; François Raffi; Catherine Leport
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen.
AIDS (London, England) 2002;16(1):21-9.
2001: Christian Michelet; Annick Ruffault; Véronique Sébille; Cédric Arvieux; P Jaccard; François Raffi; C Bazin; Jean-Marc Chapplain; Jean-Pierre Chauvin; E Dohin; F Cartier; Eric Bellissant
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2001;45(12):3393-402.
2001: Daniel Scott-Algara; Jean-Pierre Aboulker; Christine Durier; Edgar Badell; Fabienne Marcellin; M Prud'homme; C Jouanne; Vincent Meiffredy; Françoise Brun Vezinet; Gilles Pialoux; François Raffi
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.
Clinical and experimental immunology 2001;126(2):295-303.
2001: Patrizia Carrieri; Valérie Cailleton; Vincent Le Moing; Bruno Spire; Pierre Dellamonica; E Bouvet; François Raffi; Valérie Journot; Jean-Paul Moatti
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort.
Journal of acquired immune deficiency syndromes (1999) 2001;28(3):232-9.
2001: Vincent Le Moing; Geneviève Chêne; Maria Patrizia Carrieri; Jean-Marc Besnier; Bernard Masquelier; R Salamon; C Bazin; J P Moatti; François Raffi; Catherine Leport
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):372-6.
2001: Véronique Reliquet; N Robillard; Philippe Perré; Jean-Yves Muller; François Raffi; Marie Audrain
[Immunologic response to antiretroviral treatment with combined stavudine, didanosine and nevirapine].
Presse médicale (Paris, France : 1983) 2001;30(23):1143-7.
2001: Charlotte Lewden; François Raffi; Geneviève Chêne; A Sobel; Catherine Leport
Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population.
Journal of acquired immune deficiency syndromes (1999) 2001;26(5):480-2.
2001: Véronique Reliquet; J-M G Mussini; JM Chennebault; Alain Lafeuillade; François Raffi
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
HIV medicine 2001;2(2):92-6.
2001: J Hoff; F Bani-Sadr; M Gassin; François Raffi
Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(6):963-9.
2001: C Rabaud; Isabelle Charreau; S Izard; François Raffi; Vincent Meiffredy; Catherine Leport; F Guillemin; Patrick Yeni; Jean-Pierre Aboulker
Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression.
Scandinavian journal of infectious diseases 2001;33(10):759-64.
2001: S Duran; Bruno Spire; François Raffi; V Walter; D Bouhour; Valérie Journot; Valérie Cailleton; Catherine Leport; Jean-Paul Moatti
Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.
HIV clinical trials 2001;2(1):38-45.
2000: François Raffi; Véronique Reliquet; Virginie Ferré; Cédric Arvieux; C Hascoet; V Bellein; Jean-Marc Besnier; JP Breux; Michel Garré; thierry may; Jean-Michel Molina; Philippe Perré; G Raguin; Willy Rozenbaum; David Zucman
The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults.
Antiviral therapy 2000;5(4):267-72.
2000: M Savès; François Raffi; P Clevenbergh; B Marchou; Anne Waldner-Combernoux; P Morlat; Vincent Le Moing; C Rivière; Geneviève Chêne; Catherine Leport
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.
Antimicrobial agents and chemotherapy 2000;44(12):3451-5.
2000: François Raffi; B Bonnet; Virginie Ferré; J L Esnault; Philippe Perré; Véronique Reliquet; S Leautez; C Bouillant; O Vergnoux; P Weinbreck
Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1274-8.
2000: Jean-Michel Molina; Françoise Ferchal; Corinne Rancinan; François Raffi; Willy Rozenbaum; Daniel Sereni; Philippe Morlat; Valérie Journot; JM Decazes; Geneviève Chêne
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 2000;182(2):599-602.
2000: Pierre-Marie Girard; P S Pegram; Bertrand Diquet; R Anderson; François Raffi; Roland Tubiana; D Sereni; D Boerner
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.
Journal of acquired immune deficiency syndromes (1999) 2000;23(3):227-35.
2000: Diane Descamps; Philippe Flandre; Vincent Calvez; Gilles Peytavin; Vincent Meiffredy; Gilles Collin; Constance Delaugerre; S Robert-Delmas; B Bazin; Jean-Pierre Aboulker; Gilles Pialoux; François Raffi; Françoise Brun-Vézinet
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
JAMA : the journal of the American Medical Association 2000;283(2):205-11.
1999: Bruno Hoen; B Dumon; Martine Harzic; Alain Venet; Béatrice Dubeaux; C Lascoux; Y Bourezane; Jean-Marie Ragnaud; A Bicart-See; François Raffi; L Beauvais; Hervé Fleury; D Séréni
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial.
The Journal of infectious diseases 1999;180(4):1342-6.
1999: Christian Michelet; Eric Bellissant; Annick Ruffault; Cédric Arvieux; J F Delfraissy; François Raffi; C Bazin; I Renard; Véronique Sébille; Jean-Pierre Chauvin; E Dohin; F Cartier
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Clinical pharmacology and therapeutics 1999;65(6):661-71.
1999: Sophie Léautez; Firouzé Bani-Sadr; Eric Billaud; François Raffi
[Secondary prophylaxis for herpes zoster wi oral acyclovir in HIV patients].
Pathologie-biologie 1999;47(5):570-2.
1999: Clotilde Allavena; C François; Véronique Reliquet; P Perre; C Michau; G Peytavin; François Raffi
[Experience with nevirapine taken once daily in 93 HIV-infected patients].
Pathologie-biologie 1999;47(5):563-5.
1999: François Raffi; Jacqueline Franck; Hervé Pelloux; F Derouin; Véronique Reliquet; P Ambroise-Thomas; Jean-Pierre Aboulker; Catherine Leport; Henri Dumon
Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis.
Diagnostic microbiology and infectious disease 1999;34(1):51-6.
1999: Sophie Léautez; Eric Billaud; B Milpied; François Raffi
[Varicella zoster virus infection area in 39 HIV-infected patients. Therapeutic management].
Presse médicale (Paris, France : 1983) 1999;28(9):473-5.
1999: Véronique Reliquet; Virginie Ferré; C Hascoet; Jean-Marc Besnier; V Bellein; Cédric Arvieux; Jean-Michel Molina; JP Breux; David Zucman; Willy Rozenbaum; Clotilde Allavena; François Raffi
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
Antiviral therapy 1999;4 Suppl 3():83-4.
1998: Gilles Pialoux; François Raffi; Françoise Brun Vezinet; Vincent Meiffrédy; Philippe Flandre; J A Gastaut; Pierre Dellamonica; Patrick Yeni; Jean-François Delfraissy; Jean-Pierre Aboulker
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
The New England journal of medicine 1998;339(18):1269-76.
1998: François Raffi; Véronique Reliquet; S Auger; Jean-Marc Besnier; JM Chennebault; Eric Billaud; Christian Michelet; P Perre; Alain Lafeuillade; thierry may; S Billaudel
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients.
AIDS (London, England) 1998;12(15):1999-2005.
1998: Christian Michelet; Cédric Arvieux; C François; Jean-Marc Besnier; JP Rogez; JP Breux; Faouzi Souala; Clotilde Allavena; François Raffi; M Garre; F Cartier
Opportunistic infections occurring during highly active antiretroviral treatment.
AIDS (London, England) 1998;12(14):1815-22.
1998: N Denis-Delpierre; D Merrien; Eric Billaud; Jean-Marc Besnier; E Duhamel; P Hutin; F Andrieux; Caroline Delaunay; JP Rogez; P Arsac; JM Chennebault; François Raffi
[Multifocal tuberculosis. Apropos of 49 cases in the midwest region. GERICCO (Group for Epidemiology and Research in Clinical Infections of the Central West of France), 1991-1993].
Pathologie-biologie 1998;46(6):375-9.
1998: F Bani-Sadr; J Hoff; A Chiffoleau; Clotilde Allavena; François Raffi
[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].
Presse médicale (Paris, France : 1983) 1998;27(18):860.
1998: N Denis-Delpierre; D Merrien; Eric Billaud; Jean-Marc Besnier; E Duhamel; P Hutin; F Andrieux; Caroline Delaunay; JP Rogez; P Arsac; JM Chennebault; François Raffi
[Extrapulmonary tuberculosis in the central western region. Retrospective study of 217 cases (Gericco 1991-1993)].
Presse médicale (Paris, France : 1983) 1998;27(8):341-6.
1998: François Raffi; Véronique Reliquet; C Francois; M Garre; C Hascoet; Clotilde Allavena; Cédric Arvieux; JP Breux; P Perre; Willy Rozenbaum; S Auger
Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team.
Antiviral therapy 1998;3 Suppl 4():57-60.
1997: Jean-Michel Molina; J Goguel; Claudine Sarfati; C Chastang; I Desportes-Livage; JF Michiels; C Maslo; C Katlama; Laurent Cotte; Catherine Leport; François Raffi; Francis Derouin; J Modaï
Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.
AIDS (London, England) 1997;11(13):1603-10.
1997: François Raffi; Jean-Pierre Aboulker; Christian Michelet; Véronique Reliquet; Hervé Pelloux; A Huart; Isabelle Poizot-Martin; P Morlat; B Dupas; J-M G Mussini; Catherine Leport
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group.
AIDS (London, England) 1997;11(2):177-84.
1996: Christian Agard; Mohamed Hamidou; C Gires; J Y Grolleau; François Raffi
[Polynuclear neutrophils meningitis disclosing Mycoplasma pneumoniae infection].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(12):1043-4.
1996: M Tiab; F Mechinaud Lacroix; M Hamidou; F Gaillard; François Raffi
Reactive haemophagocytic syndrome in AIDS.
AIDS (London, England) 1996;10(1):108-11.
1996: B Gueglio; François Raffi; M Marjolet
[Lyme neuroborreliosis of mental manifestation. Apropos of a case].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(7):599.
1996: G Magadur-Joly; François Raffi; P Bouchut; Pascal Chevalet; D Merrien; L Struillou; Jacques-Henri Barrier
[Hematogenic bacterial endophthalmitis. A rare infection with very poor functional prognosis].
Annales de médecine interne 1996;147(3):212-7.
1996: M Tiab; F Mechinaud; Mohamed Hamidou; F Gaillard; François Raffi; Jean-Luc Harousseau
[Hemophagocytic syndromes. A series of 23 cases].
Annales de médecine interne 1996;147(3):138-44.
1996: E Ninin; D Merrien; Mohamed Hamidou; A Testa; B Milpied; François Raffi
[Thrombotic microangiopathies in HIV infection: 4 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1996;17(3):238-42.
1995: François Raffi; D Merrien; Patrice LE PAPE; Véronique Reliquet
Use of an Itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(5):1338-9.
1995: F Bani-Sadr; Mohamed Hamidou; François Raffi; C Chamoux; Jocelyne Caillon; C Freland
[Clinical and bacteriological aspects of nocardiasis. 9 cases].
Presse médicale (Paris, France : 1983) 1995;24(23):1062-6.
1995: François Raffi; L Struillou; E Ninin; Véronique Reliquet; E Billaud; B Milpied
Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(4):1076-7.
1995: M Tiab; François Raffi; Mohamed Hamidou; B Dupas; Jacques-Henri Barrier
[Paralysis of the 3d cranial nerve disclosing primary cytomegalovirus infection in an immunocompetent adult].
Annales de médecine interne 1995;146(2):130-2.
1994: L Struillou; François Raffi
[Cerebro-meningeal infections in patients with human immunodeficiency virus infections].
La Revue du praticien 1994;44(16):2187-94.
1994: M Tiab; Mohamed Hamidou; G Magadur; François Raffi; P Villon; A Prost; Jacques-Henri Barrier
[Major hyperferritinemia in Still disease in adults].
Annales de médecine interne 1994;145(3):215-6.
1994: M Tiab; François Raffi; Mohamed Hamidou; J M Mussini; Jacques-Henri Barrier
[Guillain-Barré syndrome in Horton disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(11):772-3.
1993: L Struillou; François Raffi; Jacques-Henri Barrier
Endocarditis caused by Neisseria elongata subspecies nitroreducens: case report and literature review.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(8):625-7.
1993: Christophe Camus; Catherine Leport; François Raffi; Christian Michelet; F Cartier; J L Vilde
Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(1):46-55.
1993: Dominique El Kouri; P De Faucal; François Raffi; Bernard Planchon
[Septic Campylobacter fetus thrombophlebitis: a new case].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(1):41-2.
1992: François Raffi; D Boudart; D Merrien; Jacques-Henri Barrier
Fibronectin in HIV-infected patients: a prospective study.
The European journal of medicine 1992;1(5):308-10.
1992: François Raffi; M Tiab; O Morin; F Derouin
[Cerebral toxoplasmosis concomitant with primary toxoplasma infection in AIDS].
Presse médicale (Paris, France : 1983) 1992;21(12):584-5.
1992: M Fleischmann; B Milpied; Brigitte Dréno; B Bureau; Eric Billaud; François Raffi; P Litoux
[Cutaneous Cytomegalovirus ulceration in AIDS: diagnosis by in situ hybridization and response to treatment].
Annales de dermatologie et de vénéréologie 1992;119(11):877-9.
1991: François Raffi; P Patra
[Infected aneurysms of the aorta].
La Revue du praticien 1991;41(19):1785-8.
1991: François Raffi; J M Brisseau; Bernard Planchon; J P Rémi; Jacques-Henri Barrier; J Y Grolleau
Endocrine function in 98 HIV-infected patients: a prospective study.
AIDS (London, England) 1991;5(6):729-33.
1990: D Merrien; François Raffi; J H Barbier
[Febrile purpura disclosing primary cytomegalovirus infection].
Presse médicale (Paris, France : 1983) 1990;19(36):1681-2.
1990: M Hamidou; J M Brisseau; François Raffi; F Banissadr; J Y Grolleau
[Anemia of central origin and complement activation during Mycoplasma pneumoniae infection].
Presse médicale (Paris, France : 1983) 1990;19(23):1104.
1990: François Raffi; B Feve; M Tiab; J M Brisseau; A E Reynaud; J Y Grolleau
[Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study].
Pathologie-biologie 1990;38(5 ( Pt 2)):548-51.
1990: François Raffi; E Billaud; H Dutartre; B Milpied
Thoracic Salmonella typhimurium abscess in an AIDS patient.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(1):53-4.
1990: Mohamed Hamidou; Dominique El Kouri; F Tasseau; François Raffi; M Tiab; Jacques-Henri Barrier
[Severe and early hypercalcemia in rhabdomyolysis].
Annales de médecine interne 1990;141(7):623-4.
1989: J M Brisseau; Arnaud Murat; François Raffi; J F Ramee; V Lucas; Jacques-Henri Barrier; J Guillon
[Diabetes mellitus and infections].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1989;10(5):435-41.
1988: Bernard Garo; M Garré; J J Quiot; Jean-Michel Boles; B Becq-Giraudon; JM Chennebault; Patrick Choutet; Christian Michelet; François Raffi; P Weinbreck
[Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases].
Presse médicale (Paris, France : 1983) 1988;17(29):1475-8.